VR Logo

NuVasive Inc. (NUVA) download report


Healthcare | Medical Devices & Equipment

NuVasive Inc. (NUVA) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.

IPO Date: 13-May-2004

CEO & Director: Mr. J. Christopher Barry

Exec. VP & CFO: Mr. Matthew K. Harbaugh

Listing: NASDAQ: NUVA

Country: United States

Headquarters: San Diego, CA

Website: https://www.nuvasive.com

Key Facts

Market cap: $2,636.92 Mln

Revenue (TTM): $1,158.50 Mln

Earnings (TTM): $-37.38 Mln

Cash: $205.31 Mln

Total Debt: $1,005.93 Mln

Insider's Holding: 0.22%

Liquidity: Low

52 Week range: $45.45 - 70.00

Shares outstanding: 52,041,000

10 Years Aggregate:

  • CFO: $1,589.63 Mln
  • EBITDA: $1,386.10 Mln
  • Net Profit: $157.24 Mln

Stock Performance

Time Period NuVasive (NUVA) S&P BSE Sensex* S&P Small-Cap 600*
YTD-3.05-8.71-17.14
1 month-8.75-3.11-4.85
3 months-2.04-7.30-12.74
1 Year-27.200.48-16.37
3 Years-3.8410.347.97
5 Years-7.8811.436.33
10 Years8.2612.1010.54
As on 27-Jun-2022 *As on 28-Jun-2022
Year NuVasive (NUVA) S&P Small-Cap 600 S&P BSE Sensex
2021-6.8325.2721.99
2020-27.179.5715.75
201956.0520.8614.38
2018-15.19-9.705.87
2017-13.1711.7327.91
201624.4924.741.95
201514.74-3.36-5.03